Financial actions considered by CFOs as a result of COVID-19 U.S. 2020

Published by Statista Research Department, Jul 5, 2024
In a June 2020 survey, 79 percent of surveyed CFOs said that they were considering implementing cost containment as a result of the COVID-19 pandemic. The outbreak of COVID-19 has caused companies to reconsider their financial activities.

Which of the following financial actions is your company considering as a result of COVID-19?

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2020

Region

United States

Survey time period

June 8 to 11, 2020

Number of respondents

330 respondents

Special properties

CFOs

Supplementary notes

Multiple responses were possible.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " The COVID-19 pandemic "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you The COVID-19 pandemic

Overview

6

Cases and deaths by country

8

Vaccinations

7

Focus: Public opinion

8

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus COVID-19 in ChinaDiabetes in ChinaPharmaceutical industry in ChinaVaccine industry in ChinaFitness industry in China
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.